Emerging Biopharma

Dedicated Solutions for Emerging Biopharma Companies

You’re excited by the opportunities your new compound presents. However, as it advances through each stage of the clinical trial process, the cost and complexities continue to increase. These challenges escalate when you go to market.

Quintiles has a select biotech consultant team with firsthand experience. Through these experts, you can access our full range of clinical, commercial, financial and operational infrastructure and resources, including practitioners with in-depth therapeutic expertise.

Biotech portfolio services include:

  • Strategic counseling on pharmaceutical compliance and clinical drug development issues
  • Pharmaceutical marketing and sales
  • Virtual drug development

Virtual drug development means our ability to integrate all clinical trial phases on every level:

Contact Us

Clinical Services

US: 1 866 267 4479
Intl: Click for toll-free access by country

Dedicated Solutions for Emerging BioPharma

Emerging Biopharma Service Fact Sheet

Recognizing that the needs of emerging companies are unique, Quintiles has created a specialized team dedicated exclusively to small and mid-sized biopharma companies.

Read more

Fact

Almost 70% of our customers are emerging or medium-sized biotech companies.

Case Study

Enabling Transformation

Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company.

Learn more

Case Study

Gain Capital & Retain Value

Cell Therapeutics was in need of capital to fund ongoing development expenses, but was not interested in further equity dilution. As an alternative, they considered monetizing a royalty interest in Trisenox®, their only marketed oncology product.

Learn more

Others also viewed